Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867334 · ClinicalTrials.gov registry record · Phase 1
New Individualized Therapy Trial for Metastatic Colorectal Cancer
A Phase 1 study, sponsored by Inova Health Care Services.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00867334 is a Phase 1 study that has completed, run by Inova Health Care Services. The registered enrollment target is 10 participants.
The verdict
NCT00867334, a Phase 1 study, has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of imatinib mesylate in combination with panitumumab for the treatment of stage IV colorectal cancer that has spread to the liver. It will also assess the whether imatinib mesylate, either alone or in combination with panitumumab, is effective in treating this type of cancer. In addition, the study will evaluate the feasibility of a predefined lab score and whether it can predict which patients will respond to treatment with imatinib mesylate.
Interventions
- DRUG Imatinib mesylate and panitumumab
- DRUG Standard-of-care treatment with panitumumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00867334
The ClinicalTrials.gov registry entry for NCT00867334 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Imatinib mesylate and panitumumab is the first listed.
NCT00867334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00867334 about?
NCT00867334 is a clinical study titled "New Individualized Therapy Trial for Metastatic Colorectal Cancer". The purpose of this study is to evaluate the safety and tolerability of imatinib mesylate in combination with panitumumab for the treatment of stage IV colorectal cancer that has spread to the liver. It will also assess the whether imatinib mesylate, either alone or in combination with panitumumab, ...
What is the current status of trial NCT00867334?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-06. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00867334?
The interventions under investigation include: Imatinib mesylate and panitumumab (DRUG), Standard-of-care treatment with panitumumab (DRUG).
Who is sponsoring clinical trial NCT00867334?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.